August 3, 2005 HOT TOPICS NEWS & INFORMATION: TOOLS FOR: RESOURCES:  >  > Attention Business Editor: Biotech Remains on a Roll in July SAN FRANCISCO, Aug. 1 /CNW/ -- Any thoughts that July would be a quiet month for the biotech sector and the markets in general were quickly dispelled following a very active month. Despite some market apprehensions caused by the Chinese yuan revaluation and the tragic events surrounding the bombings in London's transit system, the markets closed the month with very positive gains. For the month, the Burrill Biotech Select Index gained 8.5%, the Dow closed up 3.5% and NASDAQ was up 6.2%. "The number of companies whose second quarter earnings exceeded expectations was much higher than expected," said G. Steven Burrill, CEO of Burrill & Company, a San Francisco based global leader in life sciences with princi

more...